Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Spinal anesthesia increases the risk of venous thromboembolism in total arthroplasty: Secondary analysis of a J-PSVT cohort study on anesthesia.

Nakamura M, Kamei M, Bito S, Migita K, Miyata S, Kumagai K, Abe I, Nakagawa Y, Nakayama Y, Saito M, Tanaka T, Motokawa S.

Medicine (Baltimore). 2017 May;96(18):e6748. doi: 10.1097/MD.0000000000006748.

2.

Mortality following primary total knee replacement in public hospitals in Hong Kong.

Lee QJ, Mak WP, Wong YC.

Hong Kong Med J. 2016 Jun;22(3):237-41. doi: 10.12809/hkmj154712. Epub 2016 May 6.

3.

Preoperative Risk Factors for, and Incidence of Delayed Surgery in Elective Primary Total Knee Arthroplasty After Hospital Admission: The ACS-NSQIP.

Phruetthiphat OA, Gao Y, Vasta S, Zampogna B, Piperno A, Noiseux NO.

J Arthroplasty. 2016 Jul;31(7):1413-6. doi: 10.1016/j.arth.2015.04.047. Epub 2015 Jun 3.

PMID:
26994648
4.

Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.

Bito S, Miyata S, Migita K, Nakamura M, Shinohara K, Sato T, Tonai T, Shimizu M, Shibata Y, Kishi K, Kubota C, Nakahara S, Mori T, Ikeda K, Ota S, Minamizaki T, Yamada S, Shiota N, Kamei M, Motokawa S.

Blood. 2016 Feb 25;127(8):1036-43. doi: 10.1182/blood-2015-06-651620. Epub 2015 Dec 9.

5.

[Rivaroxaban versus standard of care in venous thromboembolism prevention following hip or knee arthroplasty in daily clinical practice (Spanish data from the international study XAMOS)].

Granero J, Díaz de Rada P, Lozano LM, Martínez J, Herrera A; en nombre de los investigadores del grupo XAMOS España.

Rev Esp Cir Ortop Traumatol. 2016 Jan-Feb;60(1):44-52. doi: 10.1016/j.recot.2015.05.009. Epub 2015 Jul 17. Spanish.

PMID:
26194908
6.

Factors influencing the outcome of deep infection following total knee arthroplasty.

Nakano N, Matsumoto T, Ishida K, Tsumura N, Muratsu H, Hiranaka T, Kuroda R, Kurosaka M.

Knee. 2015 Sep;22(4):328-32. doi: 10.1016/j.knee.2015.04.005. Epub 2015 May 1.

PMID:
25937092
7.

Risk of venous thromboembolism after total knee arthroplasty in patients with rheumatoid arthritis.

Izumi M, Migita K, Nakamura M, Jiuchi Y, Sakai T, Yamaguchi T, Asahara T, Nishino Y, Bito S, Miyata S, Kumagai K, Osaki M, Mawatari M, Motokawa S.

J Rheumatol. 2015 Jun;42(6):928-34. doi: 10.3899/jrheum.140768. Epub 2015 Apr 15. Erratum in: J Rheumatol. 2016 Mar;43(3):681.

PMID:
25877506
8.

The association between comorbidities and pain, physical function and quality of life following hip and knee arthroplasty.

Peter WF, Dekker J, Tilbury C, Tordoir RL, Verdegaal SH, Onstenk R, Bénard MR, Vehmeijer SB, Fiocco M, Vermeulen HM, van der Linden-van der Zwaag HM, Nelissen RG, Vliet Vlieland TP.

Rheumatol Int. 2015 Jul;35(7):1233-41. doi: 10.1007/s00296-015-3211-7. Epub 2015 Jan 14.

9.

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.

Migita K, Bito S, Nakamura M, Miyata S, Saito M, Kakizaki H, Nakayama Y, Matsusita T, Furuichi I, Sasazaki Y, Tanaka T, Yoshida M, Kaneko H, Abe I, Mine T, Ihara K, Kuratsu S, Saisho K, Miyahara H, Segata T, Nakagawa Y, Kamei M, Torigoshi T, Motokawa S.

Arthritis Res Ther. 2014 Jul 21;16(4):R154. doi: 10.1186/ar4616.

10.

Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes.

Danninger T, Rasul R, Poeran J, Stundner O, Mazumdar M, Fleischut PM, Poultsides L, Memtsoudis SG.

ScientificWorldJournal. 2014 Jan 21;2014:623460. doi: 10.1155/2014/623460. eCollection 2014.

11.

Risk factors for revision within 10 years of total knee arthroplasty.

Dy CJ, Marx RG, Bozic KJ, Pan TJ, Padgett DE, Lyman S.

Clin Orthop Relat Res. 2014 Apr;472(4):1198-207. doi: 10.1007/s11999-013-3416-6. Epub 2013 Dec 18.

12.

Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial.

Horstmann W, Kuipers B, Ohanis D, Slappendel R, Kollen B, Verheyen C.

Blood Transfus. 2014 Jan;12 Suppl 1:s176-81. doi: 10.2450/2013.0072-13. Epub 2013 Jul 26.

13.

What are the causes of revision total knee arthroplasty in Japan?

Kasahara Y, Majima T, Kimura S, Nishiike O, Uchida J.

Clin Orthop Relat Res. 2013 May;471(5):1533-8. doi: 10.1007/s11999-013-2820-2.

14.

One-stage bilateral total hip arthroplasty: functional outcomes and complications in 112 patients.

Trojani C, d'Ollonne T, Saragaglia D, Vielpeau C, Carles M, Prudhon JL; French Society for Hip and Knee (SFHG).

Orthop Traumatol Surg Res. 2012 Oct;98(6 Suppl):S120-3. doi: 10.1016/j.otsr.2012.06.008. Epub 2012 Aug 30.

15.

Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.

Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I, Muller SD.

J Bone Joint Surg Am. 2012 Sep 5;94(17):1554-8.

PMID:
22832942
16.

Total knee arthroplasty has higher postoperative morbidity than unicompartmental knee arthroplasty: a multicenter analysis.

Brown NM, Sheth NP, Davis K, Berend ME, Lombardi AV, Berend KR, Della Valle CJ.

J Arthroplasty. 2012 Sep;27(8 Suppl):86-90. doi: 10.1016/j.arth.2012.03.022. Epub 2012 May 4.

PMID:
22560653
17.

Complications for racial and ethnic minority groups after total hip and knee replacement: a review of the literature.

Nwachukwu BU, Kenny AD, Losina E, Chibnik LB, Katz JN.

J Bone Joint Surg Am. 2010 Feb;92(2):338-45. doi: 10.2106/JBJS.I.00510. Review.

18.

BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.

Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kälebo P, Misselwitz F, Gent M; OdiXa-Knee Study Group.

J Thromb Haemost. 2005 Nov;3(11):2479-86.

19.

Predicting the outcome of total knee arthroplasty.

Lingard EA, Katz JN, Wright EA, Sledge CB; Kinemax Outcomes Group.

J Bone Joint Surg Am. 2004 Oct;86-A(10):2179-86.

PMID:
15466726
20.

Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial.

Møller AM, Villebro N, Pedersen T, Tønnesen H.

Lancet. 2002 Jan 12;359(9301):114-7.

PMID:
11809253

Supplemental Content

Loading ...
Support Center